_gynecologic-cancer-education-parp-inhibitor-therapy-preview-1.jpg "Gynecologic Cancer Education: PARP Inhibitor Therapy from parp Video Screenshot Preview 1")
Gallery_gynecologic-cancer-education-parp-inhibitor-therapy-preview-3.jpg "Gynecologic Cancer Education: PARP Inhibitor Therapy from parp Video Screenshot Preview 3")
Gallery_gynecologic-cancer-education-parp-inhibitor-therapy-preview-hqdefault.jpg "Gynecologic Cancer Education: PARP Inhibitor Therapy from parp Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 24 minutes 56 seconds
👁 View: 2.3K times
Play Audio:👁 View: 2.3K times
Description:
Mayo Clinic
Mayo Clinic
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_the-role-of-parp-inhibitors-in-advanced-prostate-cancer-2023.webp "AUAUniversity")
_brca-amp-parp-inhibitors-targeted-chemotherapy-124-markscholzmd-alexscholz-pcri.webp "Prostate Cancer Research Institute")
⏲ 11 minutes 49 seconds 👁 1.9K
_carmel-jo-pezaro-mb-chb-on-prostate-cancer-and-parp-inhibitors.webp "Carmel Jo Pezaro, MB, ChB, of Monash University, discusses the optimal integration of PARP inhibitors for prostate cancer: which test, patient, and therapy.")
_parp-inhibitors-for-maintenance-therapy-in-ovarian-cancer.webp "Cleveland Clinic")
_mechanism-of-action-of-parp-inhibitors-and-targeting-dna-damage-response-ddr.webp "Understand the mechanism of action of PARP inhibitors and targeting DNA Damage Response (DDR) in this short video")
⏲ 3 min 10 sec ✓ 25-Jul-2019
_personalizing-advanced-ovarian-cancer-treatment-with-parp-inhibitors-and-novel-approaches.webp "PeerView Oncology")
⏲ 57 minutes 11 seconds 👁 2.5K
_bono-parp-qu-tan-caro-est2024-gus-lucioni.webp "Gustavo Lucioni")
_susana-m-campos-md-mph-on-the-role-of-parp-inhibitors-in-the-treatment-landscape-of-ovarian-cancer.webp "Susana M. Campos, MD, MPH, of Dana-Farber Cancer Institute, discusses recent changes to the NCCN Ovarian Cancer Guidelines and the implications for treatment going forward.")
⏲ 1 min 37 sec ✓ 26-Apr-2018
_the-role-of-parp-inhibitors-in-advanced-prostate-cancer-2023.jpg)
_brca-amp-parp-inhibitors-targeted-chemotherapy-124-markscholzmd-alexscholz-pcri.jpg)
_carmel-jo-pezaro-mb-chb-on-prostate-cancer-and-parp-inhibitors.jpg)
_parp-inhibitors-for-maintenance-therapy-in-ovarian-cancer.jpg)
_mechanism-of-action-of-parp-inhibitors-and-targeting-dna-damage-response-ddr.jpg)
_personalizing-advanced-ovarian-cancer-treatment-with-parp-inhibitors-and-novel-approaches.jpg)
_bono-parp-qu-tan-caro-est2024-gus-lucioni.jpg)
_susana-m-campos-md-mph-on-the-role-of-parp-inhibitors-in-the-treatment-landscape-of-ovarian-cancer.jpg)
![[+]](/images/menu.gif){kind=small}